Matt Keeling

Fund Controller


Matt focusses on the financial and operational management of the London Stock Exchange-listed International Biotechnology Trust plc, whilst also providing financial and transactional support for the London SV Health Investor teams.


Matt came to SV Health Investor after five years at PwC, where he was responsible for managing a portfolio of audit clients, which predominantly consisted of large, FTSE-listed financial services organizations and small, alternative asset managers. Prior to becoming an accountant, Matt worked as a research scientist for GlaxoSmithKline.


Matt has a MChem & BSc (First Class), Chemistry; Chartered Accountant (ACA).



  • You are seeing this because you are accessing IBT’s website for the first time.


  • The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.


  • An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.


  • The material on this website is intended to be viewed only by persons resident in the EEA.


  • The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.


  • No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.


  • The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).